VINCIARELLI PATRIZIO sold $5.4M of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $270.93 ($261.82–$277.61, $5.42M total) across 14 trades on 2026-06-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 9, 2026, 5:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 9, 2026, 5:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The CEO/Chairman’s open-market sale totaling ~$5.42M could create short-lived negative sentiment, but the 10b5-1 plan suggests the trades were scheduled in advance.

02

Market read

A primary-source insider sale was disclosed, but the 10b5-1 framing likely limits interpretive impact.

03

What to watch

Traders may over-weight insider sales; the key is whether there are concurrent fundamental updates (earnings, guidance, contracts) not present in this text.

Relevance 5/10Novelty 8/10Timing: Filed 2026-06-09; sale executed 2026-06-08.

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s Chairman/CEO sold $5.42M of VICR shares via an open-market sale under a pre-arranged 10b5-1 plan on 2026-06-08.

Expected impact

Likely limited near-term impact; any reaction may fade unless accompanied by other fundamental/regulatory catalysts.

Evidence & confidence

The filing is a primary-source Form 4 showing a sizable sale, but it explicitly states a pre-arranged 10b5-1 plan, which typically dampens interpretive value versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect routine liquidity/compensation rather than bearish expectations.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO; reported the sale of VICR shares.

  • Rule 10b5-1 plan

    Pre-arranged plan cited as Yes, indicating scheduled selling.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$VICRHighAI 8/10

Why is Vicor stock climbing today?

Vicor Corporation (VICR) stock rose 2.6% in morning trading, extending gains after its Q3 2026 earnings beat expectations. Revenue was $197.1M, up 78.5% YoY, with adjusted EPS of $1.33. Gross margin expanded to 68.3%, and the order backlog grew 166% YoY to $406M. Analysts maintained Buy ratings with price targets of $350 and $375. The stock traded at $209.36, above its 52-week low of $79 but below its high of $382.65.